Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 107.64
+3.68 (3.54%)
At close: Sep 30, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 14.16 billion as of October 2, 2026. Its market cap has increased by 62.52% in one year.
Market Cap
14.16B
Enterprise Value
13.83B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
107.64
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 14.16B, an increase of 221.66%. That is a compound annual growth rate of 18.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 14.16B | 90.85% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.43B |
| BrightGene Bio-Medical Technology | 15.59B |
| GemPharmatech | 15.52B |
| Anhui Anke Biotechnology (Group) | 14.35B |
| Nanjing Vazyme Biotech | 14.08B |
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |